Midecamycin
|
|
|
- CAS-Nr.
- 35457-80-8
- Bezeichnung:
- Midecamycin
- Englisch Name:
- MIDECAMYCIN
- Synonyma:
- medemycin;mydecamycin;medecamycin;sf837;Aboren;Myoxam;Midecin;Momicin;Macropen;MoMicine
- CBNumber:
- CB5175530
- Summenformel:
- C41H67NO15
- Molgewicht:
- 813.97
- MOL-Datei:
- 35457-80-8.mol
|
Midecamycin Eigenschaften
- Schmelzpunkt:
- 155℃ -156℃
- Siedepunkt:
- 874℃
- alpha
- D23 -67° (c = 1 in ethanol)
- Dichte
- 1.1651 (rough estimate)
- Brechungsindex
- 1.6220 (estimate)
- Flammpunkt:
- >110°(230°F)
- storage temp.
- Keep in dark place,Inert atmosphere,2-8°C
- L?slichkeit
- Chloroform (Slightly), Ethanol (Slightly), Methanol (Slightly)
- Aggregatzustand
- Solid
- pka
- 6.9 in 50% aq ethanol
- Farbe
- White to Off-White
- Wasserl?slichkeit
- Soluble in methanol or ethanol. Insoluble in water
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| Bildanzeige (GHS) |
|
| Alarmwort |
|
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H413 |
Kann für Wasserorganismen sch?dlich sein, mit langfristiger Wirkung. |
Langfristig (chronisch) gew?ssergef?hrdend |
Kategorie 4 |
|
|
|
|
| Sicherheit |
|
Midecamycin Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Midecamycin, a macrolide antibiotic having a 16-membered lactone ring, was found in the culture broth of Streptomyces mycarofaciens by Meiji Seika Kaisha in 1971. Under specific culture conditions, it is produced by the organism as a single component. Midecamycin shows almost the same antimicrobial spectrum and activity as kitasamycin. Although its serum and urine concentrations are low, it distributes in tissues at high concentration following oral administration.
Chemische Eigenschaften
White Solid
Verwenden
A 16-membered ring macrolide antibiotic used in ophthalmology as well as other medical fields.
Pharmazeutische Anwendungen
A naturally occurring metabolite of Streptomyces mycarofaciens, supplied as the native compound and as midecamycin acetate for oral administration.
It is rapidly and extensively metabolized and is said to exhibit less toxicity than earlier macrolides. It is of limited availability.
Midecamycin Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Midecamycin Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 138)Lieferanten
35457-80-8(Midecamycin)Verwandte Suche:
- midecamycina(sub1)
- platenomycinb1
- LeucoMycin V 3,4B-Dipropanoate
- MoMicine
- antibioticsf837
- sf837
- turimycinp(sub3)
- LEUCOMYCIN V 3,4B-DIPROPIONATE
- Aboren
- Leucomycin V, 3,4B-dipropanoate (9CI)
- Macropen
- Medecamycin A1
- Medemycin A1
- Midecamycin A1
- Midecin
- Momicin
- Mydecamycin A1
- Myoxam
- Normicina
- NSC 154011
- Oxacyclohexadecane, leucomycin V deriv.
- Rubimycin
- SF 837A1
- Turimycin P3
- YL 704B1
- MIDECAMYCIN
- MIDECAMYCINE
- midecamycin from streptomyces*mycarofaciens
- MIDECAMYCIN FROM STREPTOMYCES &
- Leucomycin V 3,4''-dipropionate
- Leucomycin V 3,4B-dipropionate
- antibioticsf837a1
- antibioticyl704b1
- espinomycina
- leucomycinv,3,4(supb)-dipropanoate
- propanoic acid [(11Z,13E)-6-[[(2S,3R,4R,5S,6R)-4-(dimethylamino)-3-hydroxy-5-[[(2S,4R,5R,6R)-4-hydroxy-4,6-dimethyl-5-(1-oxopropoxy)-2-oxanyl]oxy]-6-methyl-2-oxanyl]oxy]-10-hydroxy-5-methoxy-9,16-dime
- Midecamycin, >98%
- (4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-(((2S,3R,4R,5S,6R)-4-(Dimethylamino)-3-hydroxy-5-(((2S,4R,5S,6S)-4-hydroxy-4,6-dimethyl-5-(propionyloxy)tetrahydro-2H-pyran-2-yl)oxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-ox
- (4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-(((2S,3R,4R,5S,6R)-4-(Dimethylamino)-3-hydroxy-5-(((2S,4R,5S,6S)-4-hydroxy-4,6-dimethyl-5-(propionyloxy)tetrahydro-2H-pyran-2-yl)oxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)oxacyclohexadeca-11,13-dien-4-yl propionate
- (2S,3S,4R,6S)-6-{[(2R,3S,4R,5R,6S)-4-(dimethylamino)-5-hydroxy-6-{[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-4-(propanoyloxy)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy}-2-methyloxan-3-yl]oxy}-4-hydroxy-2,4-dimethyloxan-3-yl propanoate
- Midecamycin (>85%)
- MIDECAMYCIN USP/EP/BP
- DMUAPQTXSSNEDD-BJXZGPOLSA-N
- medemycin
- mydecamycin
- medecamycin
- 35457-80-8
- 3557-80-8
- C41H67NO15
- Pharmaceuticals
- Carbohydrates & Derivatives
- Chiral Reagents
- Intermediates & Fine Chemicals
